plerixafor has been researched along with ly2510924 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chevassut, T; Ladikou, EE; Pepper, AG; Pepper, CJ | 1 |
1 review(s) available for plerixafor and ly2510924
Article | Year |
---|---|
Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzylamines; Bone Marrow; Cell Adhesion; Cell Hypoxia; Cell Movement; Cell-Derived Microparticles; Chemokine CXCL12; Clinical Trials as Topic; Cyclams; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; Heterocyclic Compounds; Humans; Leukemia, Myeloid, Acute; Mice; Molecular Targeted Therapy; Neoplasm Proteins; Neoplastic Stem Cells; Peptides; Peptides, Cyclic; Pyridines; Receptors, CXCR4; Signal Transduction; Stem Cell Niche; Stromal Cells; Tumor Microenvironment | 2020 |